Clinical Trials in Finland — Country Dashboard | 533 EU Studies

Filter these 533 trials by condition, phase, sponsor and more.

Open in Search →

533 Registered trials

230 Recruiting

238 Completed trials

176 Sponsors active

100 Research sites

Phase III

Phase II

Phase IV

Phase III: 281 Phase II/III: 30 Phase II: 90 Phase I/II: 21 Phase III/IV: 9 Phase IV: 66 Phase I: 10 Phase I (Other): 16 Phase I (FiH): 8 Other: 2

Oversight events in trials active here:

42 serious breaches 167 temporary halts 8 urgent safety measures 21 unexpected events 28 corrective measures across 75 trials

View oversight register →

Top conditions

Non-small cell lung cancer 10 Prostate cancer metastatic 7 Ovarian cancer 6 Obesity 5 Endometrial cancer 4 Bladder cancer 3 Respiratory syncytial virus infection 3 Breast cancer metastatic 3 Coronary artery disease 3 Multiple sclerosis 3 Influenza 3 Myelodysplastic syndrome 3

Top sponsors

Merck Sharp & Dohme LLC 41 HUS-Yhtymae 30 Pfizer Inc. 25 Boehringer Ingelheim International GmbH 18 Turku University Hospital 17 Boehringer Ingelheim Espana S.A. 16 Glaxosmithkline Research & Development Limited 16 AstraZeneca AB 13 Bayer AG 12 Bristol-Myers Squibb Services Unlimited Company 12 Novartis Pharma AG 12 Pirkanmaan hyvinvointialue 12

Cities with most trials

All 30 cities →

All trials — page 4

533 total

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder Recruiting

2025-523202-32-00 Phase III Major Depressive Disorder Xenon Pharmaceuticals Inc.
A clinical study of enlicitide in children with high cholesterol (MK-0616-029) Recruiting

2024-519068-42-00 Phase II/III Heterozygous Familial Hypercholesterolemia in pediatric pa… Merck Sharp & Dohme LLC
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRES… Recruiting

2025-522170-36-00 Phase III Diabetes Mellitus, Type 1 Eli Lilly & Co.
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Phase III Acute Myeloid Leukemia Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
EASE SBS 5 (Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS) Recruiting

2024-512486-14-00 Phase III Short Bowel Syndrome Zealand Pharma A/S
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults (BARICADE-DELAY) Recruiting

2025-521797-34-00 Phase III Diabetes Mellitus, Type 1 Eli Lilly & Co.
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL. Recruiting

2025-522052-13-00 Phase II/III Framework for Optimizing, Refining, and Unifying Management … Ospedale Pediatrico Bambino Gesu
A clinical study of the anti-cancer effects of an investigational therapy or chemotherapy in patients with recurring uterine cancer Recruiting

2023-507525-42-00 Phase III Endometrial cancer BioNTech SE
Study to investigate lifileucel regimen plus pembrolizumab compared with pembrolizumab alone in participants with untreated, advanced melano… Recruiting

2022-503140-41-00 Phase III Melanoma Iovance Biotherapeutics Inc.
A randomized controlled phase II, double blinded trial to investigate pulmonary function after treatment with rituximab compared to placebo … Recruiting

2024-517667-23-00 Phase II Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Oslo University Hospital HF
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-… Recruiting

2025-520982-39-00 Phase III Philadelphia Chromosome Positive or ABL-class Philadelphia C… Universita Degli Studi Di Milano Bicocca
Long-term study to assess the safety and tolerability of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519423-24-00 Phase III Major Depressive Disorder Neurocrine Biosciences Inc.
A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab vs Chemotherapy plus Pembrolizumab as First-Line Treatment o… Recruiting

2023-508056-19-00 Phase III HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient… AstraZeneca AB
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008) Recruiting

2024-518296-56-00 Phase III Crohn’s Disease Merck Sharp & Dohme LLC
Clinical study of ruxolitinib and venetoclax for children with relapsed or refractory leukemia or lymphoma with mutations in the IL-7R/JAK-S… Recruiting

2022-501867-42-01 Phase I/II Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic Lymph… Princess Maxima Center For Pediatric Oncology
Medical-scientific study of dasatinib and venetoclax for children with relapsed or refractory leukemia or lymphoma with a mutation in the MA… Recruiting

2022-501866-22-00 Phase I/II Acute Lymphoblastic Leukemia, in Relapse Lymphoblastic Lymph… Princess Maxima Center For Pediatric Oncology
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Phase III Bronchiectasis Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
COLCOT-T2D Recruiting

2024-516646-19-00 Phase III Type 2 diabetic patients with no prior cardiovascular (CV) e… Montreal Heart Institute
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Phase III Acute Myeloid Leukemia (AML) Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Restarting Early versus Later Anticoagulation for Chronic Subdural Hematoma with Atrial Fibrillation (RELACS) Recruiting

2025-521179-29-00 Phase II/III Chronic subdural hematoma HUS-Yhtymae
A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft-Versus-Host Disease A… Recruiting

2024-518973-32-00 Phase III Chronic Graft-Versus-Host Disease Incyte Corp.
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Phase IV Acute critical illness requiring intensive care unit admissi… Rigshospitalet
Belimumab CTD-ILD - Long Term Extension/Follow up to pivotal studies BLISSc-ILD and BEconneCTD-ILD Recruiting

2023-509370-39-00 Phase III connective tissue diseases Glaxosmithkline Research & Development Limited
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants from Approximately 2 Months of Age Recruiting

2023-507600-32-00 Phase III Pneumococcal Immunization Sanofi Pasteur Inc.

Showing 73–96 of 533 trials

← All countries